Evaluation of BCG Vaccine in Excessive Dermal Reactivity Test
DOI:
https://doi.org/10.7439/ijbar.v6i11.2649Abstract
BCG vaccine has been in use globally to control the tuberculosis since the year 1921 and there has been significant achievement to curtail the disease. The important tests as per pharmacopoeial requirements including count of viable units (CVU) and excessive dermal reactivity (EDR) are required to be performed for ensuring the quality of BCG vaccine. In order to see the trend analysis of EDR of BCG vaccine used in India, a study has been carried out using 35 batches of BCG vaccine manufactured by two different manufacturers. The results of EDR of 16 batches of manufacturer-1 and 19 batches from manufacturer-2 ranged from 2.7mm to 3.2mm and1.9mm to 3.9mm respectively and the results are not markedly different from that of reference vaccine. The preliminary observation based on 16 batches suggests that there is some correlation between CVU and EDR of BCG vaccine, however more batches of BCG vaccine need to be tested to draw a clear correlation between these two tests. The critical EDR test is required to be performed regularly till the suitable alternate in vitro method is established. Overall results of the study suggest that BCG vaccine used in India is safe and potent.
Downloads
References
Calmette A, Plotz H. Protective inoculation against tuberculosis with BCG. Am. Rev. Tub1929; 19: 567-572.
European Pharmacopoeia. BCG vaccine, freeze dried. 7.0; 2011; 747-748.
Indian Pharmacopoeia. Bacillus Calmette Guerin vaccine (freeze dried).2014; 3057-3060.
WHO. Recommendations to assure the quality, safety and e?cacy of BCG vaccines. 2013; WHO Technical Report Series No. 979.
Lugosi L. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology. A review. Tuberc Lung Dis1992; 73:252-261
Gheorghiu M, Lagrange P, Fillastre C. The stability and immunogenicity of a dispersed-grown freeze dried Pasteur BCG vaccine. J Biol Stand1998; 16:15-26.
Milstien JB, Gibson JJ. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull WHO1990; 68:93-108
Engibarov A, Chouchkova M, Koychev C. Studies on the quality control of BCG vaccine: Laboratory examinations and postvaccination control in the field. Dev Biol Stand1986; 58:163-171.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
